Viral Structural Proteins
"Viral Structural Proteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Viral proteins that are components of the mature assembled VIRUS PARTICLES. They may include nucleocapsid core proteins (gag proteins), enzymes packaged within the virus particle (pol proteins), and membrane components (env proteins). These do not include the proteins encoded in the VIRAL GENOME that are produced in infected cells but which are not packaged in the mature virus particle,i.e. the so called non-structural proteins (VIRAL NONSTRUCTURAL PROTEINS).
Descriptor ID |
D015678
|
MeSH Number(s) |
D12.776.964.970
|
Concept/Terms |
Viral Structural Proteins- Viral Structural Proteins
- Proteins, Viral Structural
- Structural Proteins, Viral
- Virus Structural Proteins
- Proteins, Virus Structural
- Structural Proteins, Virus
|
Below are MeSH descriptors whose meaning is more general than "Viral Structural Proteins".
Below are MeSH descriptors whose meaning is more specific than "Viral Structural Proteins".
This graph shows the total number of publications written about "Viral Structural Proteins" by people in this website by year, and whether "Viral Structural Proteins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 1 | 0 | 1 |
1997 | 1 | 0 | 1 |
1998 | 1 | 0 | 1 |
1999 | 1 | 0 | 1 |
2002 | 0 | 1 | 1 |
2004 | 1 | 0 | 1 |
2005 | 5 | 2 | 7 |
2006 | 2 | 2 | 4 |
2007 | 1 | 3 | 4 |
2009 | 1 | 0 | 1 |
2010 | 0 | 1 | 1 |
2011 | 0 | 1 | 1 |
2013 | 1 | 1 | 2 |
2014 | 1 | 0 | 1 |
2015 | 2 | 0 | 2 |
2016 | 1 | 1 | 2 |
2017 | 3 | 5 | 8 |
2018 | 3 | 3 | 6 |
2019 | 1 | 2 | 3 |
2020 | 3 | 2 | 5 |
2021 | 2 | 1 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Viral Structural Proteins" by people in Profiles.
-
SARS-CoV-2 Proteins: Are They Useful as Targets for COVID-19 Drugs and Vaccines? Curr Mol Med. 2022; 22(1):50-66.
-
Understanding structural malleability of the SARS-CoV-2 proteins and relation to the comorbidities. Brief Bioinform. 2021 11 05; 22(6).
-
SARS-CoV-2 Proteins Bind to Hemoglobin and Its Metabolites. Int J Mol Sci. 2021 Aug 21; 22(16).
-
Severe acute respiratory syndrome coronavirus-2 and its structural proteins. J Cell Physiol. 2022 01; 237(1):9.
-
Identification of HLA-A2 restricted CD8+ T cell epitopes in SARS-CoV-2 structural proteins. J Leukoc Biol. 2021 12; 110(6):1171-1180.
-
Broad T Cell Targeting of Structural Proteins After SARS-CoV-2 Infection: High Throughput Assessment of T Cell Reactivity Using an Automated Interferon Gamma Release Assay. Front Immunol. 2021; 12:688436.
-
Current Update on Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Development with a Special Emphasis on Gene Therapy Viral Vector Design and Construction for Vaccination. Hum Gene Ther. 2021 06; 32(11-12):541-562.
-
Role of Structural and Non-Structural Proteins and Therapeutic Targets of SARS-CoV-2 for COVID-19. Cells. 2021 04 06; 10(4).
-
A study on non-synonymous mutational patterns in structural proteins of SARS-CoV-2. Genome. 2021 Jul; 64(7):665-678.
-
Population-Predicted MHC Class II Epitope Presentation of SARS-CoV-2 Structural Proteins Correlates to the Case Fatality Rates of COVID-19 in Different Countries. Int J Mol Sci. 2021 Mar 05; 22(5).